Results 121 to 130 of about 37,925 (344)

Exceptional Points of Degeneracy Induced by Linear Time-Periodic Variation [PDF]

, 2019
We present a general theory of exceptional points of degeneracy (EPD) in periodically time-variant systems. We show that even a single resonator with a time-periodic component is able to develop EPDs, contrary to parity-time- (PT) symmetric systems that ...
Abdelshafy, AF, Capolino, F, Kazemi, H, Mealy, T, Nada, MY   +4 more
core  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Active inductor shunt peaking in high-speed VCSEL driver design

, 2013
An all transistor active inductor shunt peaking structure has been used in a prototype of 8-Gbps high-speed VCSEL driver which is designed for the optical link in ATLAS liquid Argon calorimeter upgrade. The VCSEL driver is fabricated in a commercial 0.25-
Gong, Datao, Hou, Suen, Jin, Ge, Liang, Futian, Liu, Chonghan, Liu, Tiankuan, Su, Da-Shung, Teng, Ping-Kun, Xiang, Annie, Ye, Jingbo   +9 more
core   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

Molecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu, Xixi Lin, Emil Mladenov, Veronika Mladenova, Jürgen Thomale, Ali Sak, Yao Wang, Yunxuan Deng, Eleni Gkika, Martin Stuschke, George Iliakis   +10 more
wiley   +1 more source

A Switched-Coupled-Inductor Quasi-Z-Source Network With High Boost Capability

IEEE Access
This paper proposes a new high gain quasi-Z-source network (qZSN) using a two-winding switched-coupled-inductor (SCL). By employing a two-winding SCL within the impedance network, the proposed topology offers high boost capability at low shoot-through ...
Mehran Moslehi Bajestan, Hamed Bizhani
doaj   +1 more source

One‐cycle controllability of high step‐up Boost converter with coupled inductor [PDF]

, 2023
Jiuxu Song, Zhiwei Chang, Hongxia Liu, Shuai Ding   +3 more
openalex   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

Molecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Single-Phase Multilevel Inverter With a Coupled Inductor

IEEE Access
Multilevel inverters have become indispensable components in various power electronic applications, particularly in medium-and high-voltage scenarios.
Noor Jaafar Jawad Alradhawi, Sirin Koc, Khaled Heshamt Barakat Mohamed Ghazy, Abdolhamid Moallemi Khiavi   +3 more
doaj   +1 more source

Zero-Voltage-Switching Boost Converter Using a Coupled Inductor [PDF]

, 2011
Hyun‐Lark Do
openalex   +1 more source

Emerging strategies to target metastasis and therapy resistance in melanoma

Molecular Oncology, EarlyView.
Emerging studies propose new approaches to interfere with melanoma progression. In recognition of melanoma awareness month, at Molecular Oncology, we highlight recently published research articles, focusing on novel therapeutic targets driving metastatic spread and outlining different strategies to overcome resistance to BRAF inhibitors and anti‐PD‐1 ...
Amel Aziba
wiley   +1 more source